Clinical Trial

Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The purpose of this study is to complete performance testing of our custom optical coherence tomography (OCT) device to verify it can deliver retinal images of similar quality to a commercial OCT device. We will then add an angle-resolved low coherence interferometry (a/LCI module) to the device to make measurements of retinal tissue structure.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-13.
Trial Details
NCT Number NCT07425106
Lead Sponsor Duke University
Collaborators: National Institute on Aging (NIA)
Conditions Optical Coherence Tomography of Retina, Alzheimer Disease
Enrollment 82 participants
Start Date 2026-02-13
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-25